(-)-Neothiobinupharidine (CHEM114495)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-06 01:52:24 UTC | ||||||||
| Update Date | 2026-05-21 01:28:04 UTC | ||||||||
| Accession Number | CHEM114495 | ||||||||
| Identification | |||||||||
| Common Name | (-)-Neothiobinupharidine | ||||||||
| Class | Small Molecule | ||||||||
| Description | (-)-Neothiobinupharidine is an organic compound with the chemical formula C30H42N2O2S and an average molecular weight of 494.74 g/mol. (-)-Neothiobinupharidine belongs to the quinolizines, a class of organoheterocyclic compounds within the organic compounds. This compound is found in or released from 13 recorded sources across several sectors. In the electrical and electronic equipment sector, it is associated with capacitors, batteries, wires and cables, cell phones, printed circuit boards, and one additional source. It is found within textiles, leather and furnishings, specifically in carpets, rugs, and synthetic textiles. Within the food, food processing and cookware sector, it is present in food packaging. Other recorded sources include medical devices from the healthcare, pharmaceuticals and veterinary products sector, as well as lubricants from both the energy, oil and gas sector and the industrial manufacturing and chemical processing sector, along with one further sector. Recorded exposure routes for (-)-Neothiobinupharidine include oral, inhalation, and touch. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type |
| ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C30H42N2O2S | ||||||||
| Average Molecular Mass | 494.740 g/mol | ||||||||
| Monoisotopic Mass | 494.297 g/mol | ||||||||
| CAS Registry Number | 03-09-50 | ||||||||
| IUPAC Name | Not Available | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | [H][C@@]12CC[C@]3(CS[C@@]4(C3)CC[C@@]3([H])[C@H](C)CC[C@]([H])(N3C4)C3=COC=C3)CN1[C@@]([H])(CC[C@H]2C)C1=COC=C1 | ||||||||
| InChI Identifier | InChI=1S/C30H42N2O2S/c1-21-3-5-27(23-9-13-33-15-23)31-18-29(11-7-25(21)31)17-30(35-20-29)12-8-26-22(2)4-6-28(32(26)19-30)24-10-14-34-16-24/h9-10,13-16,21-22,25-28H,3-8,11-12,17-20H2,1-2H3/t21-,22-,25+,26+,27+,28+,29-,30-/m1/s1 | ||||||||
| InChI Key | WBMOHCBEBDKSBI-GUUMEGLWSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
